268 related articles for article (PubMed ID: 388718)
21. Platelets and factor VIII in von Willebrand's disease.
Green D; Potter EV
N Engl J Med; 1977 Jun; 296(23):1357. PubMed ID: 300843
[No Abstract] [Full Text] [Related]
22. Differences between heterozygous dominant and recessive von Willebrand's disease type I expressed by bleeding symptoms and combinations of factor VIII variables.
Wahlberg TB; Blombäck M; Ruggeri ZM
Thromb Haemost; 1983 Dec; 50(4):864-8. PubMed ID: 6420925
[TBL] [Abstract][Full Text] [Related]
23. Platelet factor VIII-related antigen: studies in vivo after transfusion in patients with von Willebrand disease.
Sultan Y; Jeanneau C; Lamaziere J; Maisonneuve P; Caen JP
Blood; 1978 Apr; 51(4):751-61. PubMed ID: 343837
[TBL] [Abstract][Full Text] [Related]
24. The effects of epinephrine infusion in patients with von Willebrand's disease.
Rickles FR; Hoyer LW; Rick ME; Ahr DJ
J Clin Invest; 1976 Jun; 57(6):1618-25. PubMed ID: 1084352
[TBL] [Abstract][Full Text] [Related]
25. [Diagnosis of von Willebrand's disease].
Böttcher D; Hasler K; Winckelmann G; Sutor AH; Mair D
Med Klin; 1978 Jun; 73(22):833-8. PubMed ID: 307108
[TBL] [Abstract][Full Text] [Related]
26. Factor VIII-related properties in platelets from patients with von Willebrand's disease.
Ruggeri ZM; Mannucci PM; Bader R; Barbui T
J Lab Clin Med; 1978 Jan; 91(1):132-40. PubMed ID: 304081
[No Abstract] [Full Text] [Related]
27. The spectrum of von Willebrand's disease revisited.
Bowie EJ; Fass DN; Olson JD; Owen CA
Mayo Clin Proc; 1976 Jan; 51(1):35-41. PubMed ID: 765637
[TBL] [Abstract][Full Text] [Related]
28. Investigation including VIIIR: AG multimeric analysis of a large kindred with type IIA von Willebrand's disease showing a dominant inheritance and similar gene expression in four generations.
Hill FG; Enayat MS; George AJ
Thromb Haemost; 1983 Oct; 50(3):735-9. PubMed ID: 6417821
[TBL] [Abstract][Full Text] [Related]
29. Two different types of factor VIII-related antigen in inherited variants of von Willebrand's disease.
Koie K; Kamiya T; Ishiguro J; Ogata K; Asai K
Nihon Ketsueki Gakkai Zasshi; 1978 Feb; 41(1):104-10. PubMed ID: 310616
[No Abstract] [Full Text] [Related]
30. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate--dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome.
Weiss HJ; Turitto VT; Baumgartner HR
J Lab Clin Med; 1978 Nov; 92(5):750-64. PubMed ID: 309498
[TBL] [Abstract][Full Text] [Related]
31. Concurrence of von Willebrand's disease and hemophilia A: implications for carrier detection and prevalence.
Miller CH; Hilgartner MW; Harris MB; Bussel JB; Aledort LM
Am J Med Genet; 1986 May; 24(1):83-94. PubMed ID: 3085499
[TBL] [Abstract][Full Text] [Related]
32. Measurement of canine von Willebrand factor using ristocetin and Polybrene. Diagnosis of canine von Willebrand's disease.
Rosborough TK; Johnson GS; Benson RE; Swaim WR; Dodds WJ
J Lab Clin Med; 1980 Jul; 96(1):47-56. PubMed ID: 6967101
[TBL] [Abstract][Full Text] [Related]
33. Factor VIII related antigen in platelets from patients with von Willebrand's disease: a study of eight cases.
Piovella F; Majolino I; Nalli G; Sitar GM; Cattaneo G; Malamani GD; Ascari E
Haematologica; 1976 Jun; 61(2):194-201. PubMed ID: 820607
[No Abstract] [Full Text] [Related]
34. Antibodies to factor VIII-von Willebrand factor in congenital and acquired von Willebrand's disease.
Mannucci PM; Mari D
Prog Clin Biol Res; 1984; 150():109-22. PubMed ID: 6431422
[No Abstract] [Full Text] [Related]
35. Immunohistological comparison of platelet factor 4 (PF4), fibronectin (Fn) and factor VIII related antigen (VIIIR:Ag) in human platelet granules.
Giddings JC; Brookes LR; Piovella F; Bloom AL
Br J Haematol; 1982 Sep; 52(1):79-88. PubMed ID: 6810914
[TBL] [Abstract][Full Text] [Related]
36. [Determination of the factor VIII ristocetin cofactor (Willebrand factor) using a semi-quantitative slide test. Preliminary results].
Bogaty-Yver J; Musitelli JJ; Conard J; Horellou MH; Samama M
Ann Biol Clin (Paris); 1983; 41(5):319-24. PubMed ID: 6421207
[TBL] [Abstract][Full Text] [Related]
37. Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism.
Levesque H; Borg JY; Cailleux N; Vasse M; Daliphard S; Gancel A; Monconduit M; Courtois H
Eur J Med; 1993 May; 2(5):287-8. PubMed ID: 8252160
[TBL] [Abstract][Full Text] [Related]
38. Factor VIII competitive enzyme assay: observations in von Willebrand's variants and hemophiliacs.
Yorde LD; Yorde DE; Sasse EA; Hussey CV
Clin Physiol Biochem; 1984; 2(6):298-303. PubMed ID: 6440727
[TBL] [Abstract][Full Text] [Related]
39. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
Giannini S; Mezzasoma AM; Leone M; Gresele P
Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
[TBL] [Abstract][Full Text] [Related]
40. Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's disease.
Castella A; Miller JL; Neuberg RW; Gawryl MS; Hoyer LW
Am J Clin Pathol; 1983 Nov; 80(5):745-9. PubMed ID: 6416054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
